Advertisement

Topics

"orphan status given Syntimmune pemphigus candidate" Drugs and Medication Database

20:53 EST 14th December 2018 | BioPortfolio

Here are the most relevant "orphan status given Syntimmune pemphigus candidate" Drugs and Medications that we have found in our database.

More Information about "orphan status given Syntimmune pemphigus candidate" on BioPortfolio

We have published hundreds of orphan status given Syntimmune pemphigus candidate news stories on BioPortfolio along with dozens of orphan status given Syntimmune pemphigus candidate Clinical Trials and PubMed Articles about orphan status given Syntimmune pemphigus candidate for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of orphan status given Syntimmune pemphigus candidate Companies in our database. You can also find out about relevant orphan status given Syntimmune pemphigus candidate Drugs and Medications on this site too.

Showing "orphan status given Syntimmune pemphigus candidate" Drugs and Medications, all 8

Probably Relevant

Nasal decongestant [SUPERVALU INC.]

Equaline 44-112

Possibly Relevant

Arranon [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use ARRANON safely and effectively. See full prescribing information for ARRANON. ARRANON (nelarabine) InjectionInitial U.S. Approval: 2005

Kepivance [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kepivance safely and effectively. See full prescribing information for Kepivance.Kepivance® (palifermin) For injection, for intravenous useInitial U.S. Approval: 2004

Quinapril hydrochloride/hydrochlorothiazide [Aurobindo Pharma Limited]

Quinapril Hydrochloride/Hydrochlorothiazide Tablets

Carbaglu [Orphan Europe, SARL]

These highlights do not include all the information needed to use CARBAGLU safely and effectively.  See full prescribing information for CARBAGLU.   CARBAGLU (carglumic acid) TabletsInitial U.S. Approval: 2010

Nestabs [WOMENS CHOICE PHARMACEUTICALS LLC]

Nestabs

Kineret [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kineret safely and effectively. See full prescribing information for Kineret. Kineret® (anakinra) For injection, for subcutaneous useInitial U.S. Approval: 2001

Dialyvite supreme d [Hillestad Pharmaceuticals USA]

Dialyvite Supreme D



Advertisement
Quick Search
Advertisement
Advertisement